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A series of compounds (Va-Vl) was synthesized via direct reductive amination of 3-(naphthalen-2-yl)-1-phenyl-1H-
pyrazole-4-carbaldehyde with various substituted aromatic amines using NaBH4 in the presence of I2 as a reducing agent. 
The reaction was carried out in anhydrous methanol under neutral conditions at room temperature. The structures of the 
synthesized compounds (Va-Vl) were established on the basis of IR, 1H and 13C-NMR, and mass spectral data. All 4-
(substituted-anilinomethyl-3-(2-naphthyl)-1-phenyl-1H-pyrazole derivatives (Va-Vl) were tested in vitro for antifungal 
and antibacterial activities against different fungal and bacterial strains. Most of the compounds exhibited considerable 
antifungal activity but poor antibacterial activity against the test strains. The compounds Vg, Vj and Vk showed excellent 
antifungal activity against the fungal strain Aspergillus niger MTCC 281 and Aspergillus flavus MTCC 277 (% inhibition 
in the range of 47.7-52.8). 
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INTRODUCTION 
Pyrazole scaffold represent one of the most 
active class of heterocyclic compounds possessing 
a wide spectrum of biological activities including 
anti-inflammatory–analgesic [1-3], antimicrobial 
[4,5], antihypertensive [6,7] etc. Some of the 
analogues have also shown potent antitumor [8,9], 
antidepressant - anticonvulsant [10,11] and 
hypoglycemic activities [12,13]. The significance 
of pyrazole scaffold may be realized by the fact 
that, there are numerous pyrazole containing drugs 
has been approved by USFDA for appropriate 
therapeutic indications some of which includes 
Celecoxib, Lanazolac, Sulphinpyrazone and Cefoselis 
etc. Crizotinib (Xalkori) an anticancer drug recently 
approved by USFDA for the treatment of non-small 
cell lung carcinoma (NSCLC) is pyrazole derivative 
[14]. Fig. 1 shows some of the pyrazole derived 
therapeutic agents and represent the molecular varsity 
of pyrazole nucleus. Owing to the immense 
importance and varied bioactivities of pyrazole 
scaffold and in the continuation of our ongoing 
research on biologically active pyrazole derivatives 
[15, 16], it was thought of interest to synthesized 
some new 6-methoxy naphthalene incorporated 
pyrazole derivatives. In the present study 
 
Fig. 1. Chemical structures of various pyrazole containing drugs. 
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we performed the one-pot synthesis of 4-
(substituted-anilinomethyl-3-(6-methoxy-2-
naphthyl)-1-phenyl-1H-pyrazoles and their 
antimicrobial screening against a panel of bacterial 
and fungal strains. 
EXPERIMENTAL 
Melting points were determined by the open 
capillary method with electrical melting point 
apparatus and are uncorrected. IR spectra were 
recorded as KBr (pallet) on Nicolet, Protege 460 
FTIR spectrophotometer and 1H & 13C-NMR 
spectra recorded on Bruker DPX 300 MHz 
spectrophotometer using DMSO-d6 or CDCl3 as a 
NMR solvent. TMS used as internal standard and 
chemical shift data reported in parts per million (in 
ppm) where s, bs, d, t, and m designated as singlet, 
broad singlet, doublet, triplet and multiplet 
respectively. Mass spectra (MS-ESI) were recorded 
on a JEOL-AccuTOF JMS-T100LS mass 
spectrometer with a DART (Direct Analysis in Real 
Time) and elemental analysis on C,H,N Analyzer 
Perkin Elmer 2400. Thin Layer Chromatography 
(TLC) was performed to monitor progress of the 
reaction and purity of the compounds, spot being 
located under iodine vapour or UV-light.  
Synthesis of 1-[1-(6-methoxynaphthalen-2-
yl)ethylidene]-2-phenylhydrazine (III). 
A mixture of 2-acetyl-6-methoxynaphthalene I 
(2.0 g or 0.01 mol) and phenyl hydrazine (II) 
(0.012 mol) was refluxed in round bottom flask 
containing absolute ethanol (30 ml)  for 2.0 hrs in 
presence of few drops of acetic acid. The content of 
the flask was cooled to give solid product which 
was filtered, washed with water, dried and 
recrystallized from ethanol as a yellow crystalline 
solid. The purity of compound was checked by 
TLC using (TEF) (5:4:1) as mobile phase. 
1-[1-(6-Methoxynaphthalen-2-yl)ethylidene]-2-
phenylhydrazine (III). Yellowish white solid, yield 
90 %; m.p. 183 ºC; IR  (KBr) νmax (cm -1) : 3357 
(NH), 1605 (C=C), 1590 (C=N). 1H-NMR (300 
MHz, DMSO-d6) δ:  2.36 (s, 3H, CH3), 3.91 (s, 3H, 
OCH3), 6.77-6.82 (m, 1H, Ar-H), 7.10-7.18 (m, 1H, 
Ar-H), 7.21-7.34 (m, 4H, Ar-H), 7.69-7.79 (m, 3H, 
Ar-H), 7.93 (s, 1H, Ar-H), 8.14-8.17 (d, 1H, Ar-H, 
J = 8.7 Hz), 10.4 (bs, 1H, NH) Anal. calcd. for : 
C19H18N2O; C 78.59, H 6.25, N 9.65 % Found : C 
78.33, H 6.29, N 9.72 %. 
Synthesis of 3-(6-methoxynaphthalen-2-yl)-1-
phenyl-1H-pyrazole-4-carbaldehyde (IV).  
To a cold solution of 6-methoxy naphthyl 
hydrazones III  (4.35 g or 0.015 mol) in DMF (25 
ml) was added POCl3 (5 ml) and resulting mixture 
was stirred at 55-60 ˚C for 6 hrs. The  mixture was 
cooled to room temperature and poured in to ice-cold 
water, latter a saturated solution of sodium 
bicarbonate was added to neutralize the solution. The 
precipitate so formed was filtered, washed with water, 
dried and recrystallized from ethanol as  crystalline 
solid. 
3-(6-Methoxynaphthalen-2-yl)-1-phenyl-1H-
pyrazole-4-carbaldehyde (IV). Light yellow solid, 
yield 70%, m. P. 152 ºC; IR  (KBr) νmax (cm -1) : 1671 
(C=O), 1610 (C=C), 1595 (C=N). 1H-NMR (300 
MHz, DMSO-d3) δ (ppm):  3.97 (s, 3H, OCH3), 7.19-
7.21 (m, 2H, Ar-H), 7.37-7.42 (m, 1H, Ar-H), 7.49-
7.55 (m, 2H, Ar-H). 7.81-7.93 (m, 5H, Ar-H), 8.25 (s, 
1H, Ar-H), 8.56 (s, 1H, Ar-H), 10.15 (s, 1H, CHO). 
13C-NMR (DMSO-d6, 75 MHz) δ (ppm) : 55.4 
(OCH3), 103.6,114.5, 116.9, 119.7, 125.8, 126.6, 
128.0, 128.9, 129.5, 130.2, 131.8, 132.0, 137.6, 141.2, 
157.5, 162.4, 184.0 (CHO). MS (ESI) m/z: 328 (M+), 
300 (M-28), Anal. calcd. for : C21H16N2O2, C 76.81, H 
4.91, N 8.53 %,  Found C 76.48, H 4.95, N 8.61. 
General procedure for the synthesis of compounds 
(Va-Vl). 
To a solution of 3-(6-methoxynaphthalen-2-yl)-1-
phenyl-1H-pyrazole-4-carbaldehyde IV  (1.0 mmol) 
in 10 ml of methanol, substituted aniline (1.2 mmol) 
was added and then 50 mg iodine (0.4 mmol) was 
added with stirring at room temperature. To the stirred 
solution 55 mg of sodium borohydride (1.4 mmol) 
was added slowly, stirring further for 3-6 hrs. The 
precipitate was formed which was filtered, washed 
with water, dried and recrystallized from 
ethanol/methanol to give crystalline product (Va-Vl). 
The progress of reaction and purity of the compound 
was checked by (TLC), using benzene: acetone 
(9.5:0.5) as mobile phase.  
4-Anilinomethyl-3-(6-methoxy-2-naphthyl)-1-
phenyl-1H-pyrazole (Va). Light brown solid, yield 
75%, m. P. 130-132 ºC; IR  (KBr) νmax (cm -1) 3406 
(N–H), 1619 (C=C), 1596 (C=(Vmax), 1021 (C–N). 
1H-NMR (300 MHz, CDCl3) δ (ppm) : 3.90 (s, 3H, 
OCH3), 4.47 (s, 2H, CH2), 4.72 (s, 1H, NH, D2O-
exchangeble), 6.61-6.64 (d, 2H, Ar-H, J = 8.4  Hz), 
7.04-7.07 (d, 2H, Ar-H, J = 8.1 Hz),  7.10-7.15 (m, 
3H, Ar-H), 7.29-7.35 (m, 2H, Ar-H), 7.46-7.55 (m, 
3H, Ar-H), 7.70-7.81 (m, 2H, Ar-H), 7.98-8.09 (m, 
2H, Ar-H), 8.21 (s, 1H, Ar-H). 13C-NMR (75 MHz, 
CDCl3) δ (ppm) : 38.4 (CH2), 55.4 (OCH3), 103.2, 
114.6, 116.4, 117.8, 119.2, 120.0, 125.3, 126.4, 127.6, 
129.5, 128.2, 128.9, 129.5, 130.7, 132.1, 138.6, 140.9, 
142.3, 149.4, 162.4. DEPT-135; (-ve) 38.6 (CH2). MS 
(ESI) m/z: 405 (M)+. Anal. calcd. for C27H23N3O : C 
79. 97, H 5.72, N 10.39 % ; Found: C 79.73, H 5.76, 
N 10.44%. 
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4-(4-Chloroanilinomethyl-3-(6-methoxy-2-
naphthyl)-1-phenyl-1H-pyrazole (Vb). Cream 
colored solid, yield 70%, m. P. 119-121 ºC; IR 
(KBr) νmax (cm -1) : 3411 (N–H), 1612 (C=C), 1596 
(C=N), 1036 (C–N). 1H-NMR (300 MHz, CDCl3) δ 
(ppm) : 3.93 (s, 3H, OCH3), 4.46 (s, 2H, CH2), 4.78 
(bs, 1H, NH, D2O-exchangeble), 6.67-6.69 (d, 2H, 
Ar-H, J = 8.0  Hz), 7.09-7.17 (d, 4H, Ar-H, J = 7.8 
Hz),  7.22-7.29 (m, 2H, Ar-H), 7.40-7.48 (m, 3H, 
Ar-H), 7.69-7.74 (m, 2H, Ar-H), 7.95-8.03 (m, 2H, 
Ar-H), 8.16 (s, 1H, Ar-H). MS (ESI) m/z: 439 
(M)+, 441 (M+2). Anal. calcd. for C27H22ClN3O : C 
73.71, H 5.04, N 9.55 %, Found : C 73.82, H 5.09, 
N 9.62 %. 
3-(6-Methoxy-2-naphthyl)-1-phenyl-4-(4-
toluidinomethyl)-1H-pyrazole. (Vc). Yellowish 
brown solid, yield 74%, m. P. 144 ºC;  IR (KBr) 
νmax (cm -1) : 3433 (N–H), 1620 (C=C), 1591 
(C=N), 1030 (C–N). 1H-NMR (300 MHz, CDCl3) δ 
(ppm) : 2.26 (s, 3H, CH3),  3.93 (s, 3H, OCH3), 
4.46 (s, 2H, CH2), 4.80 (s, 1H, NH, D2O-
exchangeble), 6.61-6.64 (d, 2H, Ar-H, J = 8.4  Hz), 
7.01-7.03 (d, 2H, Ar-H, J = 8.1 Hz),  7.12-7.15 (m, 
2H, Ar-H), 7.25-7.30 (m, 2H, Ar-H), 7.43-7.48 (m, 
2H, Ar-H), 7.68-7.80 (m, 3H, Ar-H), 7.92-7.99 (m, 
2H, Ar-H), 8.16 (s, 1H, Ar-H). 13C-NMR (75 MHz, 
CDCl3) δ: 20.4 (CH3), 37.9 (CH2), 55.4 (OCH3), 
104.1, 114.4, 116.6, 117.4, 119.2, 120.6, 125.7, 
126.3, 127.2, 127.8, 128.2, 128.8, 129.6, 130.2, 
132.6, 135.8, 137.1, 138.2, 140.5, 142.8, 149.1, 
162.8. DEPT-135; (-ve) 37.9 (CH2). MS (ESI) m/z: 
419 (M)+,  Anal. calcd. for C28H25N3O : C 80.16, H 
6.01, N 10.02 %,  Found : C 80.34, H 6.06, N 10.7 
%. 
4-(4-Bromoanilinomethyl-3-(6-methoxy-2-
naphthyl)-1-phenyl-1H-pyrazole. (Vd). brownish 
solid, yield 68%, m. P. 189-192 ºC;  IR (KBr) νmax 
(cm -1) : 3424 (N–H), 1624 (C=C), 1596 (C=N), 
1028 (C–N). 1H-NMR (300 MHz, CDCl3) δ (ppm) : 
3.90 (s, 3H, OCH3), 4.49 (s, 2H, CH2), 5.01 (bs, 
1H, NH, D2O-exchangeble), 6.70-6.73 (d, 2H, Ar-
H, J = 8.0  Hz), 7.08-7.15 (m, 3H, Ar-H, J = 7.8 
Hz),  7.20-7.25 (m, 2H, Ar-H), 7.30-7.34 (m, 1H, 
Ar-H), 7.42-7.51 (m, 3H, Ar-H), 7.72-7.78 (m, 2H, 
Ar-H), 7.90-7.98 (m, 2H, Ar-H), 8.18 (s, 1H, Ar-
H). Anal. calcd. for C27H22BrN3O : C 66.95, H 4.58, 
N 8.67 % Found : C 66.72, H 4.63, N 8.73 %. 
4-(3-Chloroanilinomethyl-3-(6-methoxy-2-
naphthyl)-1-phenyl-1H-pyrazole. (Ve). Beize 
colored  solid, yield 65%, m. P. 110-112 ºC;  IR 
(KBr) νmax (cm -1) : 3418 (N–H), 1621 (C=C), 1593 
(C=N), 1027 (C–N). 1H-NMR (300 MHz, CDCl3) δ 
(ppm) : 3.94 (s, 3H, OCH3), 4.47 (s, 2H, CH2), 4.82 
(bs, 1H, NH, D2O-exchangeble), 6.69-6.72 (d, 2H, 
Ar-H, J = 8.0  Hz), 6.83-6.87 (m, 1H, Ar-H), 7.01-
7.08 (m, 3H, Ar-H),  7.18-7.25 (m, 2H, Ar-H), 7.37-
7.45 (m, 3H, Ar-H), 7.68-7.78 (m, 2H, Ar-H), 6.97-
7.03 (m, 2H, Ar-H), 8.20 (s, 1H, Ar-H). Anal. calcd. 
for C27H22ClN3O : C 73.71, H 5.04, N 9.55 % Found : 
C 73.54, H 5.01, N 9.62 %.  
4-(4-Methoxyanilinomethyl)-3-(6-methoxy-2-
naphthyl)-1-phenyl-1H-pyrazole (Vf). Yellowish 
brown solid, yield 71%, m. P. 103-105 ºC;  IR (KBr) 
νmax (cm -1) : 3420 (N–H), 1628 (C=C), 1597 (C=N), 
1029 (C–N). 1H-NMR (300 MHz, CDCl3) δ (ppm) : 
3.69 (s, 3H, OCH3), 3.94 (s, 3H, OCH3), 4.50 (s, 2H, 
CH2), 4.78 (bs, 1H, NH, D2O-exchangeble), 6.60-6.72 
(d, 2H, Ar-H, J = 8.0  Hz), 6.96-6.98 (d, 2H, Ar-H, J 
= 8.0  Hz), 7.10-7.19 (m, 3H, Ar-H),  7.23-7.27 (m, 
1H, Ar-H), 7.36-7.48 (m, 3H, Ar-H), 7.71-7.79 (m, 
2H, Ar-H), 6.98-7.05 (m, 2H, Ar-H), 8.19 (s, 1H, Ar-
H).  Anal. calcd. for C28H25N3O2 :  C 77.22, H 5.79, N 
9.65 % Found C 77.47, H 5.82, N 9.73 %. 
4-(4-Fluoroanilinomethyl-3-(6-methoxy-2-
naphthyl)-1-phenyl-1H-pyrazole (Vg). Light brown 
solid, yield 78%, m. P. 134-136 ºC;  IR (KBr) νmax 
(cm -1) : 3420 (N–H), 1628 (C=C), 1597 (C=N), 1029 
(C–N). 1H-NMR (300 MHz, CDCl3) δ (ppm) : 3.91 (s, 
3H, OCH3), 4.52 (s, 2H, CH2), 4.79 (bs, 1H, NH, 
D2O-exchangeble), 6.63-6.65 (d, 2H, Ar-H, J = 8.0 
Hz), 7.01-7.04 (m, 1H, Ar-H), 7.09-7.15 (m, 2H, Ar-
H),  7.24-7.30 (m, 3H, Ar-H), 7.41-7.45 (m, 2H, Ar-
H), 7.73-7.80 (m, 3H, Ar-H), 7.01-7.06 (m, 2H, Ar-
H), 8.15 (s, 1H, Ar-H).  Anal. calcd. for C27H22FN3O : 
C 76.58, H 5.24, N 9.92 % Found C 76.27, H 5.29, N 
9.97 %. 
3-(6-Methoxy-2-naphthyl)-4-(4-nitroanilino 
methyl)-1-phenyl-1H-pyrazole  (Vh). Yellowish 
brown solid, yield 75%, m. P. 168170 ºC;  IR (KBr) 
cm νmax (cm -1) : 3428 (N–H), 1631 (C=C), 1590 
(C=N), 1033 (C–N). 1H-NMR (300 MHz, CDCl3) δ 
(ppm) : 3.92 (s, 3H, OCH3), 4.48 (s, 2H, CH2), 4.76 
(bs, 1H, NH, D2O-exchangeble), 6.60-6.63 (d, 2H, Ar-
H, J = 8.0  Hz), 7.06-7.11 (m, 2H, Ar-H), 7.17-7.20 
(m, 1H, Ar-H),  7.28-7.33 (m, 3H, Ar-H), 7.43-7.47 
(m, 2H, Ar-H), 7.80-7.88 (m, 3H, Ar-H), 8.02-8.07 
(m, 2H, Ar-H), 8.21 (s, 1H, Ar-H). Anal. calcd. for 
C27H22N4O3 : C 71.99, H 4.92, N 12.44 % Found : C 
72.21, H 4.96, N 12.51 %.  
3-(6-Methoxy-2-naphthyl)-1-phenyl-4-(3-
toluidinomethyl)-1H-pyrazole (Vi). Light brown solid, 
yield 75%, m. P. 106-107 ºC;  IR (KBr) νmax (cm -1) : 
3417 (N–H), 1625 (C=C), 1594 (C=N), 1031 (C–N). 
1H-NMR (300 MHz, CDCl3) δ (ppm) :  2.24 (s, 3H, 
CH3), 3.89 (s, 3H, OCH3), 4.50 (s, 2H, CH2), 4.81 (bs, 
1H, NH, D2O-exchangeble), 6.59-6.62 (d, 2H, Ar-H, J 
= 8.0  Hz), 6.93-6.97 (m, 2H, Ar-H), 7.07-7.13 (m, 
2H, Ar-H),  7.21-7.24 (m, 1H, Ar-H), 7.40-7.49 (m, 
3H, Ar-H), 7.68-7.77 (m, 3H, Ar-H), 8.01-8.07 (m, 
2H, Ar-H), 8.17 (s, 1H, Ar-H). Anal. calcd. for 
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C28H25N3O : C 80.16, H 6.01, N 10.02 %,  Found : 
C 80.01, H 6.06, N 10.08 %.  
4-(3-Chloro-4-fluoroanilinomethyl-3-(6-
methoxy-2-naphthyl)-1-phenyl-1H-pyrazole (Vj). 
Brownish solid, yield 67%, m. P. 124-125 ºC;  IR 
(KBr) νmax (cm -1) : 3422 (N–H), 1630 (C=C), 1593 
(C=N), 1034 (C–N). 1H-NMR (300 MHz, CDCl3) δ 
(ppm) : 3.92 (s, 3H, OCH3), 4.48 (bs, 2H, CH2), 
4.71 (bs, 1H, NH, D2O-exchangeable), 6.50-6.53 
(m, 1H, Ar-H),  6.68-6.70 (m, 1H, Ar-H), 6.91-6.97 
(m, 1H, Ar-H), 7.07-7.23 (m, 3H, Ar-H), 7.39-7.54 
(m, 3H, Ar-H), 7.67-7.96 (m, 4H, Ar-H), 8.04 (s, 
1H, Ar-H), 8.12 (s, 1H, Ar-H), Anal. calcd. for 
C27H21ClFN3O : C 70.82, H 4.62, N 9.18% Found : 
C 70.63, H 4.67, N 9.24 %. 
4-(3,4-Dichloroanilinomethyl-3-(6-methoxy-2-
naphthyl)-1-phenyl-1H-pyrazole (Vk). Light brown 
solid, yield 69 %, m. P. 176-177 ºC; IR (KBr) νmax 
(cm -1) : 3428 (N–H), 1631 (C=C), 1598 (C=N), 
1033 (C–N). 1H-NMR (300 MHz, CDCl3) δ (ppm) :  
3.93 (s, 3H, OCH3), 4.46 (s, 2H, CH2), 4.86 (bs, 
1H, NH, D2o-exchangeable), 6.52-6.55 (m, 1H, Ar-
H),  6.70-6.72 (m, 1H, Ar-H), 6.91-6.97 (m,1H, ), 
7.10-7.24 (m, 3H, Ar-H), 7.42-7.51 (m, 3H, Ar-H), 
7.70-7.98 (m, 4H, Ar-H), 8.06 (s, 1H, Ar-H), 8.18 
(s, 1H, Ar-H),  Anal. calcd. for C27H21Cl2N3O : C 
68.36, H 4.46, N 8.86 Found : C 68.15, H 4.49, N 
8.92 %.  
3-(6-Methoxy-2-naphthyl)-4-(4-hydroxyanilino 
methyl)-1-phenyl-1H-pyrazole (Vh). Dark 
yellowish solid, yield 65 %, m. P. 165-166 ºC;  IR 
(KBr) cm νmax (cm -1) : 3432 (N–H), 3389(OH) 
1634 (C=C), 1594 (C=N), 1031 (C–N). 1H-NMR 
(300 MHz, CDCl3) δ (ppm) : 3.93 (s, 3H, OCH3), 
4.46 (s, 2H, CH2), 4.82 (bs, 1H, NH, D2O-
exchangeble), 6.74-6.76 (d, 2H, Ar-H, J = 7.4  Hz), 
7.09-7.12 (m, 2H, Ar-H), 7.18-7.20 (m, 1H, Ar-H),  
7.30-7.36 (m, 3H, Ar-H), 7.42-7.48 (m, 2H, Ar-H), 
7.86-7.93 (m, 3H, Ar-H), 8.03-8.07 (m, 2H, Ar-H), 
8.24 (s, 1H, Ar-H), 9.79 (bs, 1H, OH). Anal. calcd. for 
C27H23N3O2 : C 76.94, H 5.50, N 9.97 % Found : C 
76.73, H 5.52, N 10.02 %.  
Antimicrobial activity 
The newly synthesized compounds were screened 
for their antifungal and antibacterial activities against 
the test organism viz. Candida albicans MTCC-183, 
Aspergillus niger MTCC 281, Aspergillus flavus 
MTCC 277, Escherichia coli NCTC 10418, 
Staphylococus aureus NCTC 6571, Pseudomonas 
aeruginosa NCTC 10662 in DMSO by cup plate 
method [17]. Potato dextrose agar and nutrient agar 
were used as culture medium for antibacterial and 
antifungal activity respectively. Using an agar punch, 
wells were made on these seeded agar plates and 
dilution of 500 µg/ml of test compounds in DMSO 
was added into each well, labeled previously. A 
control was also prepared using solvent DMSO. The 
petri plate were prepared and maintained at 30° for 72 
hrs for fungi and at 37 ºC for 24 hrs for bacteria. Each 
experiment was repeated twice and the average of the 
two independent determinations was recorded. 
Antimicrobial activity was determined by measuring 
zone of inhibition and results were reported as 
percentage inhibition and  calculated as 100(C–T)/C, 
where C is the average diameter of fungal or bacterial 
growth on the control plate and T is the average 
diameter of fungal or bacterial growth on test plate. 
Activity of each compound was compared with 
standard Fluconazole for antifungal and Ciprofloxacin 
for antibacterial activity. Results of antimicrobial 
activity have been summarized in Table 1 
 
Table 1. In-vitro antimicrobial activity data of compounds (Va-Vl).  
Compd. No. 
Antimicrobial activity as  % inhibition 
Antifungal activity Antibacterial activity 
C. albicans A. flavus A. niger E. coli S. aureus P. auroginosa 
Va 28.1 33.8 31.7 19.6 13.7 ─ 
Vb 38.2 42.0 43.6 16.9 17.4 ─ 
Vc 26.0 30.8 32.3 22.5 13.8 ─ 
Vd 31.8 39.6 38.0 21.7 18.7 ─ 
Ve 38.4 45.7 46.1 18.6 14.3 ─ 
Vf 26.1 32.5 30.3 24.9 18.2 ─ 
Vg 38.9 48.9 48.7 20.9 15.6 ─ 
Vh 14.8 18.6 15.7 32.3 21.5 ─ 
Vi 24.7 26.8 28.8 15.7 10.8 ─ 
Vj 42.2 49.6 51.0 22.9 18.2 ─ 
Vk 44.8 52.8 50.3 23.7 20.4 ─ 
Vl 34.6 38.3 40.6 33.6 27.9 ─ 
Ciprofloxacin NT NT NT 84.8 78.7 80.6 
Fluconazole 81.5 89.8 92.6 NT NT NT 
NT: not tested, (─): no activity observed. 
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Fig. 2. Route of synthesis for compounds (Va-Vl). Reagent and conditions: (a) Abs. EtOH, reflux (b) DMF/POCl3, 55-60 
ºC, warm (c) aromatic amines, NaBH4/I2, MeOH, stirring  
RESULTS AND DISCUSSION 
Chemistry 
The compounds (Va-Vl) were synthesized by 
direct reductive amination of 3-(6-
methoxynaphthalen-2-yl)-1-phenyl-1H-pyrazole-4-
carbaldehyde with suitable aromatic amine using 
NaBH4 in the presence of I2 as reducing agent in 
absolute methanol as outlined in Fig. 2. The 
structure of synthesized amines (Va-Vl) were 
elucidated by combined use of IR, 1H & 13C-NMR 
and mass spectral data. Combustion analysis of 
compounds was found to be within the range of 
±0.4 %. The synthesis of compounds was 
confirmed on the basis of functional group 
transformation of –CHO in compound IV into –
CH2NH– in compounds (Va-Vl) and this was 
established on the basis of IR, 1H, 13C-NMR 
including mass spectral data. In FTIR the 
characteristic carbonyl (C=O) stretching band 
which was observed at 1671 cm-1 in compound IV 
disappeared in FTIR spectra of compounds (Va-
Vl). This was further supported by 1H-NMR 
spectra. The 1H-NMR spectrum of compound IV, 
the signal due to aldehydic proton which resonated 
as a singlet at δ value 10.15, disappeared in spectra 
of compounds (Va-Vl) and a new signal observed 
at high upfield δ values ranging from 4.46 to 4.52 
integrating for two protons. The signal due to the 
NH proton was observed at δ value 4.72–5.01. The 
methylene group of –CH2NH– appeared as a singlet 
or broad singlet (bs) due to coupling effect of NH 
proton whereas the NH signal was observed as a 
broad singlet. Furthermore in the 13C-NMR spectrum 
of the compound IV the signal due to the carbonyl 
carbon observed at δ value 184.0. No carbonyl carbon 
signal was found in the spectra of compounds (Va-Vl) 
and a new signal due to methylene carbon of –
CH2NH– appeared at δ value 38.4 and 38.9 in 
compound Va and Vc respectively. The functional 
group transformation was again inveterate by 13C-
NMR spectra using DEPT-135 techaniqe, which 
records inverse (-ve) peak for CH2 carban. The DEPT-
135 spectra of compound Va and Vc exhibit inverse (-
ve) peak at 38.6 and 37.9 respectively. The above 
spectral analysis suggest the successful reductive 
amination of pyrazole carbaldehydes IV. This fact 
was further supported by MS(ESI) spectra of 
prototype compounds Va, Vb and Vc, in which M+ 
ion peak was observed at m/z 405, 439 and 419 
respectively. In 1H-NMR the protons of naphthalene 
and phenyl rings were observed in aromatic region as 
multiplets due to coupling and overlapping of signals. 
While a singlets integrating for one proton appeared at 
δ value 8.12-8.24 arising due to H-5 proton of the 
pyrazole nucleus. These data are in agreement with 
structures assigned to the compounds (Va-Vl).  
Antimicrobial activity of (Va-Vl). 
All the pyrazolyl amines (Va-Vl) displayed 
variable growth inhibitory effects against the fungal 
strains at concentration of 500 mg/ml in DMSO as 
shown in Table No 1 Among the series of compounds 
(Va-Vl) compounds Vb, Ve, Vg, Vj and Vk showed 
good antifungal activity against Candida albicans. The 
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growth inhibitory effect of compounds (Va-Vl) was 
more pronounced against the fungal strain 
Aspergillus niger MTCC 281 and Aspergillus 
flavus MTCC 277. In this series compound Vg, Vj 
and Vk showed excellent antifungal activity against 
the fungal strain Aspergillus niger MTCC 281 and 
Aspergillus flavus MTCC 277 (% inhibition in the 
range of 47.7-52.8). While rest of the compounds 
such as Va, Vc, Vd, Vf, Vi and Vl displayed 
moderate antifungal activity. Only one derivative 
expressed weak antifungal activity viz. Vh.  
All the pyrazolyl amines (Va-Vl) were also 
evaluated for antibacterial activity against the 
strains Escherichia coli NCTC 10418, 
Staphylococus aureus NCTC 6571, Pseudomonas 
aeruginosa NCTC 10662 at concentration of 500 
mg/ml in DMSO by cup plate method. A careful 
examination of Table revealed that most of 
molecules of series (Va-Vl) exhibited moderate to 
weak antibacterial activity against the test organism 
E. coli NCTC 10418, Staphylococus aureus NCTC 
6571 at the conc. of 500 µg/ml. Compounds were 
completely inactive against the strain Pseudomonas 
aeruginosa NCTC 10662.  
CONCLUSION 
The study provides successful one-pot synthesis 
4-(substituted-anilinomethyl-3-(6-methoxy-2-
naphthyl)-1-phenyl-1H-pyrazols (Va-Vl) using 
NaBH4/I2 as reducing agent. The process offers 
advantages such as good yield, simple procedure, 
use easily available reagents etc. The results of 
antimicrobial screening suggest that compounds 
were more active towards the fungal strains 
compared to the bacterial strains, In the series 
compound Vg, Vj, Vk, showed excellent antifungal 
activity against the fungal strain Aspergillus niger 
MTCC 281 and Aspergillus flavus MTCC 277 (% 
inhibition in the range of 47.7-52.8). 
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(Резюме) 
Серия от съединения (Va-Vl) бяха синтезирани чрез директно редуктивно аминиране на 3- (нафтален-2-ил) -1-
фенил-1 Н-пиразол-4-карбалдехид с различни заместени ароматни амини, използвайки NaBH4 в присъствието на I2 
като редуциращ агент. Реакцията се извършва в безводен метанол при неутрални условия и стайна температура. 
Структурите на синтезираните съединения (Va-VI), са определени въз основа на IR, 1H и 13C-ЯМР и мас 
спектрални данни. Всички 4- (заместен-анилинометил-3- (2-нафтил) -1-фенил-1Н-пиразолови производни (Va-Vl) 
бяха тествани ин витро за противогъбична и антибактериална активност срещу различни гъбични и бактериални 
щамове. Повечето от съединенията показват значителна противогъбична активност, но лоша антибактериална 
активност срещу тестваните щамове. Съединенията Vg, Vj и Vk, показват отлична противогъбична активност 
срещу гъбичните щам Aspergillus Niger MTCC 281 и Aspergillus flavus MTCC 277 (% инхибиране в обхвата от 47.7-
52.8). 
